Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Dr Matthew Snape is a guest on Sierra Leone's radio programme Pikin to Pikin Tok.

Matthew discusses the work of the Department's vaccine group on Ebola vaccines on 'Pikin to Pikin Tok' (which means child to child talk in the local language Krio), a radio series launched during the Ebola crisis. You can listen to the programme here.

The UK child rights agency 'Child to Child' and their partner in Sierra Leone, 'the Pikin to Pikin movement' were running a project in the east of Sierra Leone (in the impoverished Kailahun region where the first case of Ebola was reported) since 2011. This project aimed to enhance children's social, literacy, numeracy and life skills, but the Ebola crisis meant that the NGO's work, which required children to come together in groups, had to stop due to the health risk such gatherings would create.

'Child to Child' decided to turn to radio and commissioned radio producer Penny Boreham, who also works for BBC World Service, to produce the programmes about staying healthy during the crisis and its aftermath.

The radio project, which broadcasts Storytime programmes, music programmes and special programmes like this one on the new Ebola vaccines, is funded by Comic Relief and presented by Sierra Leonean storyteller, Usifu Jalloh.

Similar stories

Fourth COVID-19 vaccine dose provides stronger immunity boost than third dose, shows UK study

COVID-19 vaccines given as fourth doses in the UK offer excellent boosting immunity protection, according to the latest results from a nationwide NIHR-supported study.

Oral paratyphoid vaccine to begin human trials

The University of Oxford in collaboration with the University of Maryland School of Medicine (UMSoM) has begun recruiting for a Phase I/II trial of a new paratyphoid vaccine in human volunteers in Oxford.

Oxford scientist named Australian of the Year in the UK

The Oxford Vaccine Group’s Lead Statistician, Professor Merryn Voysey, received the prestigious Australian of the Year in the UK award at a gala dinner recently.

Oxford to work with Brazil to establish clinical research hub

The University of Oxford and Brazilian Ministry of Health have announced a joint initiative to set up a global health and clinical research unit in Brazil led by Professor Sue Ann Clemens CBE.

Vaccine for TB receives a $1.5 million funding boost

The Oxford-run VALIDATE Network has received $1.5 million in funding for its tuberculosis vaccine work from the Bill & Melinda Gates Foundation.

Oxford vaccine reaches one billion doses released

The University of Oxford’s and our partners AstraZeneca have today announced that one billion doses of the ChAdOx1 nCov-19 coronavirus vaccine have been released, to more than 170 countries, marking a key milestone as part of the University and AstraZeneca’s joint vision to make the available to the world, on a not-for-profit basis for the world during the pandemic, and in perpetuity for low- and middle-income countries.